tiprankstipranks
Advertisement
Advertisement
XOMA Royalty to be Acquired by Ligand Pharmaceuticals
PremiumCompany AnnouncementsXOMA Royalty to be Acquired by Ligand Pharmaceuticals
2d ago
Ligand to acquire Xoma for $39.00 per share in cash
Premium
The Fly
Ligand to acquire Xoma for $39.00 per share in cash
2d ago
Ligand to buy Xoma for $39 per share, WSJ reports
Premium
The Fly
Ligand to buy Xoma for $39 per share, WSJ reports
3d ago
Xoma price target raised to $50 from $45 at Leerink
PremiumThe FlyXoma price target raised to $50 from $45 at Leerink
2M ago
XOMA Royalty Completes Generation Bio Acquisition and Merger
Premium
Company Announcements
XOMA Royalty Completes Generation Bio Acquisition and Merger
3M ago
XOMA Royalty Appoints New Chief Financial Officer
Premium
Company Announcements
XOMA Royalty Appoints New Chief Financial Officer
3M ago
Xoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
PremiumThe FlyXoma, Takeda execute royalty sharing transaction, amend Mezagitamab agreement
4M ago
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
Premium
Ratings
Strategic Acquisitions and Partnerships Drive Xoma’s Growth: A Buy Recommendation
4M ago
Generation Bio price target lowered to $5.50 from $7 at Wedbush
Premium
The Fly
Generation Bio price target lowered to $5.50 from $7 at Wedbush
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100